Browse drugs

…o the lack of response, advanced immunosuppressive therapy with infliximab was initiated which led to a marked improvement in her conditio…

…z FP, Quera R, Simian D, Flores L, Figueroa C, Ibañez P, et al. Infliximab in inflammatory bowel disease. Is premedication necessary? Gast…

… infection therefore was started on ceftriaxone, gentamicin and metronidazole. Also, breastfeeding was switched to amino-acid formula. Initia…

…nse versus 29% in C3 and 47% in C1 (IDDF2026-ABS-0219 Figure 5. Infliximab response per subtype).Conclusions Unsupervised transcriptomic i…

…hose receiving systemic corticosteroids (cs), 57.5% (n=61) with infliximab (IFX) and 83% (n=45) receiving topical steroids.No infections o…

…ifficult intravenous (IV) access requiring a midline insertion. Aspirin 10mg/kg 4 times a day was also started at this time alongside m…

…4 were 51.5% and 45.8% for ustekinumab, and 58.7% and 55.4% for vedolizumab, respectively. In Crohn’s disease, prior infliximab use, male s…

…eutic drug monitoring. The patient was subsequently switched to vedolizumab and has since shown good clinical response. This case underscor…

…imilars represent an opportunity to reduce healthcare costs. An infliximab biosimilar (b-IFX) was introduced in our hospital in 2017. Our …

… led to 43.2% clinical remission in an Emirati CD cohort, while tofacitinib achieved clinical remission rates of 56.4% and 61.1% at 52 week…

…Infliximab, a TNF-α inhibiting monoclonal antibody, is widely used to trea…

…licated by cytomegalovirus infection, successfully treated with valganciclovir. A repeat colonoscopy demonstrated complete mucosal healing and…